News

A total of 40 patients with a variety of hematological malignancies, including leukemias and lymphomas, have been enrolled in the study, with 40 patients evaluable for safety and

The $30.6 million offering was for the sale of 981,411 units. Each unit consists of one share of exchangeable preferred stock and a warrant to acquire additional shares

The test would also employ certain proprietary reagents belonging to Bio-Rad. The agreement contemplates that the parties would enter into a limited exclusive license to the DPP technology.

According to IMS Health, US with $286.5 billion in sales, accounted for 25.5% of the total sector despite its low prescription drug turnover of 3.8% in 2007. Although

The Paris office is its ninth office abroad and the company has appointed Horia Vilcu, the former director of Walmark’s subsidiary in Romania, as its head. The company

According to the DIA, the biopharmaceutical industry in India will be worth $1 billion by 2010, up from $60 million in 2003 and $100 million in 2006. The

The company and Apex Bioventures determined that, due to current market conditions, particularly for small capitalization public biotech companies’s, terminating the merger agreement was in the best interests

Dr Chen was previously the president and CEO of Tanox, a publicly held biopharmaceutical company which was acquired by Genentech in 2007. Dr Chen holds a PhD from

Repligen is currently conducting a Phase III clinical trial to assess the sensitivity and specificity of secretin-enhanced magnetic resonance imaging (MRI) to improve the ability to detect pancreatic